🇺🇸 Dexametasone in United States

62 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Thrombocytopenia — 9 reports (14.52%)
  2. Pulmonary Embolism — 8 reports (12.9%)
  3. Dyspnoea — 7 reports (11.29%)
  4. Fatigue — 7 reports (11.29%)
  5. Neutropenia — 7 reports (11.29%)
  6. Anaemia — 6 reports (9.68%)
  7. Anaphylactic Reaction — 5 reports (8.06%)
  8. Death — 5 reports (8.06%)
  9. Blood Creatinine Increased — 4 reports (6.45%)
  10. Coordination Abnormal — 4 reports (6.45%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Dexametasone approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Dexametasone in United States?

PETHEMA Foundation is the originator. The local marketing authorisation holder may differ — check the official source linked above.